From July 1, 2023 to July 5, 2023, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 274,732 shares, representing 0.81% for KRW 2,997.69 million under the buyback announced on July 5, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,150 KRW | -1.28% | +2.50% | -29.95% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.95% | 15Cr | |
+16.73% | 12TCr | |
+13.04% | 11TCr | |
-5.80% | 2.48TCr | |
+1.69% | 2.25TCr | |
-10.09% | 1.83TCr | |
-40.52% | 1.63TCr | |
-14.00% | 1.53TCr | |
+1.18% | 1.41TCr | |
+24.18% | 1.17TCr |
- Stock Market
- Equities
- A048530 Stock
- News iNtRON Biotechnology, Inc.
- Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on July 5, 2022.